The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules.

MLA

Tahvilian, Shahram, et al. “The Presence of Circulating Genetically Abnormal Cells in Blood Predicts Risk of Lung Cancer in Individuals with Indeterminate Pulmonary Nodules.” BMC Pulmonary Medicine, vol. 23, no. 1, June 2023, p. 193. EBSCOhost, https://doi.org/10.1186/s12890-023-02433-4.

APA

Tahvilian, S., Kuban, J. D., Yankelevitz, D. F., Leventon, D., Henschke, C. I., Zhu, J., Baden, L., Yip, R., Hirsch, F. R., Reed, R., Brown, A., Muldoon, A., Trejo, M., Katchman, B. A., Donovan, M. J., & Pagano, P. C. (2023). The presence of circulating genetically abnormal cells in blood predicts risk of lung cancer in individuals with indeterminate pulmonary nodules. BMC Pulmonary Medicine, 23(1), 193. https://doi.org/10.1186/s12890-023-02433-4

Chicago

Tahvilian, Shahram, Joshua D Kuban, David F Yankelevitz, Daniel Leventon, Claudia I Henschke, Jeffrey Zhu, Lara Baden, et al. 2023. “The Presence of Circulating Genetically Abnormal Cells in Blood Predicts Risk of Lung Cancer in Individuals with Indeterminate Pulmonary Nodules.” BMC Pulmonary Medicine 23 (1): 193. doi:10.1186/s12890-023-02433-4.